← FDA Drug Approvals (Drugs@FDA)

BLENREP

BLA · Biologics License Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2025-10-23

Drug application

FDA Application #

BLA761440

Application type

Biologics License Application

Brand name

BLENREP

Generic name

BELANTAMAB MAFODOTIN

Active ingredients

BELANTAMAB MAFODOTIN-BLMF

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE LLC

Manufacturer

GlaxoSmithKline LLC

First approval

2025-10-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown